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Atria1 natriurctic pptidc(ANP) nnd brnin nrtriurclic pcplidc @PIP) huvc diffcrcnt C-terminal tail ~tru~~~rcs compared with the rathsrconccrvativc 
ring structures whish consist of 17 umino acid r&dun, To cxrminc the diffcrcm effects ofthc tuil rlructum of ANPand BNP on their inlcraction 
with receptors. WC rynthcsizcd scvcrul pcptide tinvlasr und mcrr;urcd their biolosicnl uctionr in three difl’crcnt assay systems. D&ion of tk 
C-tclminnl tuil from rut BNP did not cffcct the ve~rclrrution nclivity rrgrrina rut aortu. but it promoicd cGMP praduction in cultured rat aortic 
smooth mu& ccllr (RASMC). Deletion of ihc CXcnninal tail from rat ANP diminirhcd both vusorcl;lxunt and cGMP producing activities. In 
Y binding competition artiy with RASMC and [“‘llrdt ANlVl-28). the competition activitiw of bolh ANP ond BNP wcrc grciatly rcduccd by 
Cmtcnninul dclcrion. In &Won. WC obtained ngonirtl with novel rcccplor selcrtivity. 
Natriurctic pcplidc: C.tcrminul region: Rcccpirrr nlcctivity: Diuraic cl%c~ 
1. INTRODUCTION 
Natriurctic pcptidcs (NPs) have natriurstic, diuretic. 
and hypotcnsivc properties and arc classified into three 
types, atria1 ntltriurctic pcptidcs (ANP). brain natriu- 
rctic pcptidcs (BldP) and C-type nutriurctic prptides 
(CNP) [l-7], They hnvc an intramoltcular disulfidc 
bond which forms II ring structure with 17 amino acid 
rcsiducs. Squcncc homology in the ring region is higher 
than that in other regions, such as the N-terminal cxtcn- 
sion and C-terminal tail regions. The fact that CNP has 
no C-terminal tail structure suggests that the C-terminal 
tail regions of ANP and BNP may exert different cffccts 
through different rcccptor subtypes, Rccsptors for NPs 
are also classified into three types, type A receptor (GC- 
A), type B receptor (GC-B) and clearance receptor (C- 
receptor) [8-141. 02-A and GC-B have intraccllrrlar 
guanylatc yclasc catalytic domains to produce cGMP 
as a second mcsscngcr, and arc therefore identified as 
biological receptors. The C-rcccptor exists as a dimcr 
diffcrcntIy from GC=A and GC-B, and has been pro- 
posed to participate in ths clearance of ANP [IS]. The 
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proportion of these receptors varies from one tissue to 
mother [32.16-203. and the physiological robs of the 
rcsp&vc rsccptors arc still controversial. in this study 
WC used three assay systems to cvaluatc the change in 
receptor-selectivity profiles of synthcsizcd analogs. WC 
report on compounds with novel receptor selectivity 
and the distinct biological effects of the C-terminal 
structures of rut BNP and tat ANP. 
2. MATERIALS AND METMODS 
Rat ANP.( I-28). rut BNP45 and rut CNP.22 wcrc obtoincd from 
Pcptldc Inrlilutc, Inc. (Owku, Japan). Other pcplidc analogs wcrc 
prcpurcd by solid phas synthesis, and purified by reverse-phase 
chromulography. 
Yasorcl;laalion was mrasurcd as in [?I], Ral uortic strips (2 mm x 
5 mm, from mnlc Sprquc-Dawlcy rats) wcrc mounted on sdnlcss- 
steel hooks under I 8 rcating tension. The strip wcrc then cquilibratcd 
in u modiiicd tsrckc-Rinkcr solulion with 95%Cl, and 5% CO*. After 
ccntrxlion of thr s:rips with about 1 PM PGP?P. pcptidc solurion 
wus added cumulalivcly, cGMP producing activity in cultured rat 
uortic smooth muscle cells (RASMC) wus measured as in 1221. Cells 
wcrc wnshcd twice with Hanks solution containing 20 mM HEPES 
(pH 7.4). 0.1% bovine serum albumin (bolulion A) in the prcscncc of 
0.5 mM I~mcthyl~firobutyl xanrhinc, then trwtal with the pp~idr 
dissalvcd in the wmc solution. After IO min at 37%. cells wcrc ho- 
mogenized in 6% trichloroacctic acid. The conccnlration of cGMP 
wasdctcrmined usiny a ndioimmunoastiy kit from Ynmasa (Tokyo). 
Binding comptitinn aaaay was pcrformcd with RASMC as in 1221. 
RAWC &s were ift&~~rcd wilh I’?‘!tir AN!Vl-28) (Amrrrhllm. 
Tokyo) disaolvcd in Solution A in the prcscncc or absence of non- 
lnlxlcd pcptida for 4 h on ice. After washing with Solution A. ctlls 
wcrc lyscd with I M NIOH und counted for ihcir radioactivity, Diu- 
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relic ueWicr were mct~riurcd whh nncrthclizcd Sp~gu~-D;l\~lc~ WIS 
(mule. 8-O w&s old) us in [?I]_ Sulinc wus inrrufcbl irl Cl.1 mUminky 
lhrouuh a kmorul vein UIIIWIC~ md pcplidc solulion (IO0 ~1) war 
added intruvcnously. Urine was collrcrcd UI S-nrin intrrwb from the 
bluddcr throuyh D polyrthylsnc tube. 
3. RESULTS 
3.1, Thee rrssuy +wms co ewhtrc rtwpro* seleclii+ry 
Distribution of NP rcccpcors vurics in cissucs und 
cultured cells. Suysl CC ala [19] reported that PC12 cells 
cxprcsrcd muinly GC-A, wldc cultured RASMC ex- 
pressed the C-rcccpcor prcdominirntly and u small 
prportion of GC-B us the biological receptor. GC=A 
and GC-B huvc chc afinicies of ANPZi3NP*CND tmd 
CNP*ANF>BNP, rcspcctivcly [23], The vasorclaxrnt 
uctivitiss of NPs CO rat aorta wcrc ANPiZBNP>>CNP 
(Trrblc I, Figs. I A nnd 2A. and [ 191). This indiates tlzut 
GC-A is predominantly cxprcsscd ns biologicnl receptor 
in rat tiorcti. In ocher words, the vasorcIax:mt uccivicy 
of u pcptidc corresponds to its rcsponsc to @C-A. In a 
similar manner, the lcvcl of cCtMP produced in culcurcd 
RASMC by L\ pcptidc corresponds to its rcsponss co 
GC-5. sinss GC- B is the prcdominrrnt biological rcccp 
tar in cultured RASMC. The fibundunc C-receptor prcs- 
ent in cultured RASMC hud no effect on cGMP pro- 
duction This was confirmed by an sxpcrimcnt in which 
an CXCCM amount of C-ANF+2n. il C-rcccptor-specific 
ligund. co-cxisccd uring lipnd treatment in chc cGMP 
production assoy. C-ANF,,,:,, Ut 1 FM did not ulcer the 
dose-dependent profiles of tiny compounds tested (darn 
not shown), WC also used C-ANFt:,J_2J, in u vtrsorcltrxtrnt 
any CO cxaminc the effects of ths co-existing C-rcccp 
tar, but foiled in our attempt bccauss C-ANF,,.?,, itself 
exhibited small but significtrnt vrrsorclnxation potency 
ut 1 PM (dntlr not shown). Interaction of ;1 pcptidc with 
C-receptor cun be evaluated by binding competition 
rrssuy with cultured RASMC and [?]rat ANP-(l-28). 
3.1. Ej’Jkrs uf C-rcrt~rirrrtl srrrtc~ww UII receptor sclecW 
ity 
For the molscular design of synthetic unulogs. coch 
molcculc was divided into chrcs regions. the N-ccrminnl 
had. C-terminal tail and ring regions. To dcccrmins 
which region is most importunr in recognizing the rc- 
spcctivc receptors. WC synthwizcd deletion unirlogs of 
rat NPs BS well OS chimcric trna1og.s and compared their 
rcsponac o receptors using the chrcc ussny systems dc- 
scribtd above, The results US shown in Ttlblc 1. Rut 
ANP-(7-23) (compound 1) was less active than rut 
ANP-( 1-28) (compound I) in ull assay systems which is 
consistent wilh previous reports [24,25]. In concrust. rut 
BNP-(23-31) (compound 51, ;I ring analog of rat BNP- 
45. had n similar uctivity CO rut BNP-45 (compound 3) 
in the vasarclnxution assay. The cCMP lcvcl induced by 
compound 5 wus four times higher than that by rut 
DNP-45, Binding competition activity wus greatly IOW- 
crcd. Rat CNP-(S-22) (compound 7), Irn N-terminal 
crunclltcd analog of rtlt CNP-22, wus comparable to rat 
CNP-22 (compound 6) in both vasorclaxtltion and 
cGMP producing activities, while binding competition 
uctivity wus lower thiln that of rat CNP-22. Compounds 
8 and I1 arc chimcric annlos with BNP-type C-tcrmi- 
nal tuil rsgions. Compound 8. a chimsric analog which 
combines rat ANP-(l-28) and rut BND-45. was eight 
times, two times and ten times less nccivc thun its origi- 
nal pcptidc, rat ANP-( l-28), in vasorclt\x:ttion, cGMP. 
and binding competition assays, respectively. Com- 
pound 11, a chimcric ilntllo~ combining rat CNP-22 and 
rat BNP-45. was four times less nctivc than ths original 
rut CNP-22 pcptidc in both vusorclnxntion and cGMP 
Tnblc I 
Biological activilics of rul natriurctic pcplidc unologx 
Vnsnrclnx:clion* rCiMP production** binding compclition*** 
Compounds EC,. (~10”~ M) (RnoVIO’ ccllr) I& (x10” M) 
I rut ANP.(l-?I) 3.23 t 0.52 [ I31 22ff:IS 181 0.0622~ 0.0083 [?I 
2 rut ANP.(7-21) 29.1 f 5.4 [4] 162 f I6 [3] 5.22 i: 0.6B IX] 
3 ra! BNP45 3&l + 0.99 [Sj lb9 + I11 [IO] 4.50 i 0.57 171 
4 rut BNF(23-45) 2.62 r 1.49 [4] 386 I: 22 [Ii]’ 7.34 f 1.62 [S] 
: 
rut BNP.(23-39) I.83 k 0.52 [4] 553 5 76 [S]’ 256 f 131 [41b 
rut CNP-22 4889 t 9.6 [4] 497 ?: 24 [IO] 17.1 k 2.9 [.I] 
7 rul CNP+-22) 42,7 1: 9.4 [71 504 + 32 131 292 
8 ru’111 ANP.( 1-2&m! BNWD-45) 26.5 * 4.7 [3] 123 k 2 [3] 0 (594 I ‘cf$c, ;:; 
9 rut BNF(l4-39)arut ANP.(?C28) 4.27 + 1.99 [4) 966 + 41 [3]* l:3i Z 0:3 141 
IO rat CNPZ-rat ANF(2C28) 21.3 ? 2.2 [IO] 603 r 22 [3jd 3.46 k 0.99 [4] 
II rut CNP-22.rat BNP.(40-45) I83 & 33 [iOl” 89.6 ;t 690 [3]’ 12.0 Lt 2.18 [3] 
Vnlucr urc mcnns I S.E.M. with number ol cxpcrirncnt shown in [ 1, l Vurorclux;ltion activity apins rul nortic rlrips is cxprcsacd i\s EC&. the 
conccntrulion of the psptidc which CUUSCII SO%of IIIC maximal rcluxulion achieved with 0.1 mM pupavcrinc hydrochloride. ‘*The UIIIOUII~ OfCGMP 
in cullurcd RASMC induced by cuch pcptidc ut I lM, l **Bindingcompclition activily is cxprcsrcd PL I&, the Conccntrillion ol’hc pcptidc v+hich 
UIUSCW 50% inhibition of the binding of [‘z~I]rnl ANP.(I-2%) to cuhurcd RASMC. Siynificanl difkrcnccs by Dunnctt multiplr compnrison Yr(! 3: 
followr: ‘P<O.Ol VI, rut ANP.( I-28); kPcO,Ol vs. rut BNP-45; ~kzO.01 VS. rul CNP-22: JPcO.OS VI. rul CNP.22. 
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Fig. I, Do*&pcndcnl Curves af biobgicul r~cp~or~sclcc~ivc com- 
poundri in vusorclwir~ion (A) and cGMP (B) arrays. Proccdurcs ilrC 
described in dcluil in scctian 2. The rcluxulion uclivilics wcrc normul- 
ixcd with that of 0. I mM papavcrinc hydrarhluridc as I ODQ. : :, rat 
ashilys. but twice us uctivc in the binding competition 
assay. Chimcric antilogs with rat ANP-type C&xmintrl 
tuil regions showed the quite distinct altcrtrtion in activ- 
itics from those with BNP-type tails. With compound 
9 und 10 thut hnvc ANP-type C-terminal tail regions, 
the situation was quite di&nct. Compound 9, a chim- 
cric trnrrlog combining mt BNP-45 und mt ANP-( l-28). 
had compurablc vasorclaxm uctivitp to rat BNP=4S, 
while it hsd incrcuscd activities in cGMP und binding 
competition nssuys. Compound IO. B chimcric analog 
combining rut CNP-22 und rat ANP-(i-28). was more 
active ch;ln rut CNP-22 in all assays. The dosedcpcnd- 
cnt curves of scucrul compounds in cGMP assay as well 
us vurorchlxi~tion assay arc shown in Figs. 1 and 2. 
Intcrcslingly. compounds 9 and 10 showed the higher 
cGMP producing activities (at least ten times) than rat 
CNP-22, As shown in Fig. 1 and Table I, compound 7 
showed tl greater prcfcrcncc for the GC..B rsccpcor than 
rat CNP-22 did due to ycut dctcriortltion in the affinity 
for the C-rcccptor. Compounds 5 and 9 exhibited novel 
and interesting receptor selectivity (selectivity for so- 
culled biologi=l rcccptors). Among others, compound 
5 was u very effective agonist of GC-A and GC-B rcccp- 
tars with cxtrcmcly low ilffilli[y to the Grcccptor. 
Diuretic uctivitics of rat ANP-(7-23) and rat BNP- 
(23-39) arc shown in Table 11. Rut ANP-(7-23) cxhib- 
itcd very wctlk activity ;LS expected from its low activity 
in till assays us described above. Although rat END-(23- 
39) was o very cffcct ivc agonist of both GC=A and GC=B 
rcccptors, the diuretic activity of this compound was 
also lower than rot ENP45 but the dccrcasc in activity 
was not as drastic as rat ANP-(7-23). 
4, DISCUSSION 
It is known thtlt the C-terminal tail region of rat ANP 
is importtint far its biological activity f24], This is con- 
sistent with our results thilt ri\t ANP-(7-23) WYUS 1~s~ 
n&c than rat ANP=(I-28) in sll asscryc tcstcd. The 
results shown in Table 1 give us a rough idea about the 
ligund sclcctivitics of the rcspcctivc rcccptors. First. 
both GC=A and GC-B rcccptors eem to primarily rc- 
quirc the ring structure and both hove D prcfcrcncc for 
the BNP-type ring structure. GC-B dso has a prcfcr- 
cncc for CNP-type ring structure, suggesting that the 
umiao acid rcsiducs that arc common in the rings of 
BNP and CNP. but not in that of ANP. arc important 
Tublc II 
Diurclic acWticr of rat ANP~(l-28) and BNP-45. und their ring unalogri 
Dove Urine volume 
Compound (nmolhg) (Irglmin) 
rilt ANP( t-28) 3 24.ltlf3.72 
rut ANlV7-23) 3 2.58~0.4l.Y 
rat BNP-45 
: 
27.33t4.04 
rzt 8xN2:-39) aax*i,al@ _I___ 
Yulurs urc cxprcsssd us mcnn~S.E.M, (rr=6), 
‘P<O.Ol, Ggnilicunlly diffcrcnl from rut ANP.( I-?tl] by Turkcy’r WSI, 
“fW,rj:, siynilicanlly dilkrcnt from rul BNP.45 hy furkcy’s LCYI. 
Nii cxcrction 
@Eg’min) 
4.7R~cJ.59 
0.37iO,16 
5.4l3~1,Ol 
1.53~0.21k 
K excretion 
(IrEdmin) 
0.65t0.09 
0.23~0.09” 
l.17f0.17 
0.25i0.04k 
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60. 
10 a 6 
Fig. 2 Dose-dcpcndcnr curves of compounds with hiuh cGMD pro- 
during uctiviticr. The results of vrsorcIa=tion und cGMP ss~ys arc 
rhon in A ;rnd 8. resprctivcly. Yalua xc crprcrscd in lhc slmc 
manner PI in Piy. I. 0. rut a.NP-(I-28): A, rat CNP-22; & rat 
CNW-P); a, compound IO. 
for the specific interaction bctwccn ligands and GC-B, 
Stcondly, the ring structure of ANP has a rather low 
affinity for either GC-A or GC-B. Extension of the 
C-terminal of ANP, but not of BNP, greatly improves 
its affinity for GC-A. In general, it appears that the 
ANP-type C-terminal tail promotes and the BNP-type 
tail deteriorates the specific inccruction of ligonds with 
the GC-A or GC-B rcccptor, although the mngnitudc 
of alteration diffsrs somewhat from one ligand-rcccptor 
combination to another. Thirdly, the C-receptor has a 
high selectivity for rat ANP-(I-28), recognizing not 
only the ring structure but also the C-terminal region. 
Bo:h rat BNP-45 and rat CNP-22 have weaker affinitise 
for the C-receptor than rat ANP-(I-28). In all cases, 
binding activities are reduced by deletion of the C-tcr- 
minal rrgion. 
Concerning the renal actions of NPs, the diuretic ac- 
tivitti in most ozxs, tii;t nti ahzaj+s, ahJr;iEd good 
corrcspondsncc to the vusorcluxation activities f25], 
Therefore, the great reduction in diuretic activity of rat 
ANP-(7-23) was quite reasonable, since its activity in 
both the vnsorclaxution and cCiMP assays was dimin- 
ished. On the contrary, the diuretic activity of rut BNP- 
(23-39) was not what WC expected from its vasorclnxa- 
tion and cGMP activities, Although rat BNP-(23-39) 
has comparable vasorclaxation potency to rat BNP4S 
and rat ANP-( l-28) and higher potency in cGMP assay, 
its diuretic activity was significantly lower than that of 
rat BNP-45 and rat ANP-(1-28). There is a report on 
the existence of GC-A and GC-B in kidneys [12], Sudoh 
ct al. [a] reported that CNP had diuretic activity in 
ancsthctizcd ruts, but the potency was at least 80 times 
lower than thut of ANP-(I-28) Rcccntly, Sting0 et al. 
[26] reported that CNP exhibited anti-diuretic ffccts in 
ancsthctircd ogs with a dose comparable to that used 
in our study (Table II), suggesting that the GC-B rcccp- 
tar in kidney acts repressively on tht diuretic activity of 
NP, Our observations with rat BNP-(23-39) that GC-A 
acts stimulutivcly and GC-B acts, rcprcssivcly on diu- 
rcsis coincides with that of Sting0 et al. Thcrc might bc 
a possible involvcmcnt of other types of NP rcccptors 
in diurtsis. 
TIC localiwtion of CNP. an intrinsic ligand to GC-B 
[23], seems rcstrictcd to the pituitary gland and brain, 
such as hypothulamus, thalamus, ccrcbcllum and 
midbrain, and there arc no or very small dctcstublc 
amounts of CNP in other peripheral tissues including 
circulating blood [27]. As for the tissue distribution of 
GC-8, it is also losulizcd mainly in brain but also in 
some other pcriphcr~l tissues such as lung, kidney. 
colon and adrenal medulla [ 12.18,28]. Our observation 
that rat BNP-(23-39) cffcstivcly agonized GC-B sug- 
gcsts that this form of BNP might represent an intrinsic 
ligand for peripheral GC-B rcccptor. Recent reports 
show the existence of cndopcptidnscs othrr than 
enkcphalinase that can cleave specific bonds in the ANP 
molcsulc and other pcptidc hormones [29-311. Thcrc- 
fox, it is possible that the ring by itself or similar form 
of BNP might bc found naturally. 
WC obtained compounds with novel receptor selcctiv- 
ity in the present study. Rat BNP-(23-39) and com- 
pound 9 huvc high affinity for GC-A and GC-B, and 
very low affinity for the C-receptor, and therefore, arc 
agonists with selectivity for the biological receptors. Rat 
CNP-(622) rrnd compound 10 have imprwcd GC-B 
selectivity compared to the original rut CNP-22. These 
compounds may provide good biological tools to char- 
actsrizc the physiological roles of GC-A and GC-B in 
further research. 
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